AR and age-related macular degeneration: Β-AR antagonists have recently been found to provide a therapeutic effect by counteracting several eye disorders as DR in a in vivo model [37], oxygen induced retinopathy (OIR) in a mouse model [38], and age-related macular degeneration in rabbit eyes [39].